Genome British Columbia

Genome British Columbia is a non-profit research organization based in Vancouver, Canada, established in 2000 to promote genomics innovation on the West Coast. It plays a pivotal role in integrating genomics into various sectors of society, leveraging investments primarily from the Province of British Columbia and the Government of Canada, alongside partnerships with numerous national and international funding organizations. Genome BC focuses on advancing the bioeconomy by supporting early-stage companies in diverse fields, including life sciences, health, forestry, fisheries, aquaculture, agri-food, energy, mining, and environmental sectors. Through its initiatives, Genome BC aims to foster research and entrepreneurship, ultimately contributing to the growth and development of genomics in British Columbia and beyond.

Tony Brooks

CFO and VP Entrepreneurship and Commercialization

Past deals in British Columbia

Arbutus Medical

Seed Round in 2023
Arbutus Medical Inc. is a Vancouver-based company that specializes in the development and manufacturing of surgical power tools for orthopedic surgeries. Founded in 2014, the company focuses on creating cost-effective and user-friendly devices, including its flagship orthopedic power tool system, which is designed to be affordable and accessible. Arbutus Medical aims to address the rising costs of healthcare by offering innovative solutions that enhance access to orthopedic surgery for millions of patients, particularly in low- and middle-income countries. Its product portfolio includes various tools and sterile-packed procedure kits, such as the HEX drill kit and PRO drill kit, which are utilized in North American trauma centers, veterinary hospitals, military deployments, and humanitarian missions. Through its commitment to "frugal innovation," Arbutus Medical seeks to improve surgical outcomes while reducing expenses for healthcare providers.

LightIntegra Technology

Venture Round in 2020
LightIntegra Technology Inc., established in 2009 and headquartered in Vancouver, Canada, is a privately-funded medical diagnostics company specializing in innovative in-vitro diagnostic tests. The company's flagship product, ThromboLUX, is designed to provide healthcare professionals with qualitative and quantitative information about microparticle content in platelet samples. LightIntegra offers the ThromboLUX test kit, control kit, and ThromboSight, a software tool for analyzing test results. Founded by Dr. Elisabeth Maurer, a research scientist from Canadian Blood Services R&D labs, the company aims to minimize platelet refractoriness through its products.

BarrelWise

Seed Round in 2020
BarrelWise Technologies specializes in developing innovative technology to enhance wine production and analysis. The company's flagship product, the FS1 System, revolutionizes routine free SO2 checks, enabling wineries to complete the process in minutes rather than days while ensuring lab-level accuracy. This system streamlines barrel management by allowing barrel topping, sampling, sulfating, and chemical analysis to occur in a single interaction, all without the need to open the barrel. By simplifying these processes, BarrelWise aids wineries in improving operational efficiencies and optimizing their production workflows. The company's solutions are utilized by wineries across British Columbia, California, and Washington.

Acuva

Series B in 2019
Acuva Technologies Inc. is a Canadian company based in Vancouver that specializes in the development of ultraviolet light-emitting diode (UV-LED) water purification systems. Founded in 2014, Acuva focuses on providing safe and hygienic drinking water solutions for low to moderate volumes. Its innovative technology employs UV LEDs to deliver a dose of ultraviolet radiation to water, effectively inactivating microorganisms such as viruses and bacteria by disrupting their DNA and nucleic acids. This modular and scalable system ensures the purification of water, making it suitable for various applications where safe drinking water is essential.

Starling Minds

Seed Round in 2019
Starling Minds Inc. is a Vancouver-based company that specializes in digital mental health therapy, focusing on the treatment of stress, burnout, anxiety, and depression. Founded in 2013, it offers an artificial intelligence-powered platform that delivers online Cognitive Behavioral Therapy (CBT) to enhance workplace productivity and mental health. The company provides solutions tailored for businesses, disability management, healthcare, education, insurance providers, and workers' compensation sectors. By utilizing a B2B model, Starling Minds licenses its software-as-a-service technology to employers and healthcare providers, addressing the growing demand for accessible mental health support. Their services aim to guide employees in returning to work successfully and to proactively assist those at risk of mental health challenges, helping to improve overall workplace well-being.

LightIntegra Technology

Series A in 2019
LightIntegra Technology Inc., established in 2009 and headquartered in Vancouver, Canada, is a privately-funded medical diagnostics company specializing in innovative in-vitro diagnostic tests. The company's flagship product, ThromboLUX, is designed to provide healthcare professionals with qualitative and quantitative information about microparticle content in platelet samples. LightIntegra offers the ThromboLUX test kit, control kit, and ThromboSight, a software tool for analyzing test results. Founded by Dr. Elisabeth Maurer, a research scientist from Canadian Blood Services R&D labs, the company aims to minimize platelet refractoriness through its products.

Aspect Biosystems

Venture Round in 2018
Aspect Biosystems Ltd. is a biotechnology company based in Vancouver, Canada, specializing in 3D bioprinting and tissue engineering. Founded in 2013, the company leverages proprietary microfluidic 3D bioprinting technology to develop bioprinted tissue therapeutics aimed at transforming disease treatment. By integrating therapeutic cells and materials science, Aspect Biosystems creates allogeneic cell-based tissue therapeutics that can replace or repair damaged organ functions. The company also provides a Lab-on-a-printer technology that allows precise control over biomaterial composition and structure during tissue fabrication. Its innovative platform supports the development of novel therapeutics and enhances understanding in fundamental biology and disease research, catering to pharmaceutical firms and academic institutions focused on respiratory diseases and regenerative medicine. Aspect Biosystems is actively collaborating with researchers and industry leaders to address significant challenges in the field of regenerative medicine.

Microbiome Insights

Venture Round in 2017
Microbiome Insights Inc., based in Vancouver, Canada, is a leading provider of microbiome analysis and testing services aimed at academic and industrial researchers. Founded in 2015, the company specializes in the analysis of microbial communities, including bacteria, viruses, and fungi that inhabit various environments, such as humans, animals, and plants. Microbiome Insights offers a comprehensive suite of services that includes quantifying microbial populations, analyzing the genetic potential and gene expression of microbial communities, and optimizing study design and workflow. Their multidisciplinary team comprises experts in ecology, microbiology, infectious diseases, and genetics, ensuring a high level of expertise and fast, reliable results tailored to meet the needs of clients across numerous research applications in human health, agriculture, and environmental science.

CuePath Innovation

Seed Round in 2017
CuePath Innovation Inc. is a health technology company based in Vancouver, Canada, founded in 2015. The company specializes in developing a mobile application and smart disposable medication packaging that assists caregivers in monitoring the medication intake of elderly patients and other vulnerable individuals. Through its innovative platform, CuePath connects senior citizens with their families, care professionals, and healthcare organizations, allowing for remote tracking of medication adherence. This service aims to alleviate the stress associated with caregiving by ensuring that seniors stay healthy and independent while receiving the necessary support from their circle of care. Additionally, CuePath provides medication compliance monitoring products tailored for clinical trials, utilizing blister packaging to dispense doses effectively.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.